$2.77 Billion is the total value of HealthCor Management, L.P.'s 39 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 190.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BIVV | Buy | BIOVERATIV INC | $389,601,000 | +43.1% | 6,475,000 | +29.5% | 14.06% | +12.5% |
| CELG | Buy | CELGENE CORP | $250,000,000 | +43.5% | 1,925,000 | +37.5% | 9.02% | +12.9% |
| LH | Buy | LABORATORY CORP AMER HLDGS | $211,943,000 | +44.1% | 1,375,000 | +34.1% | 7.65% | +13.4% |
| DHR | Buy | DANAHER CORP DEL | $118,343,000 | +1070.8% | 1,402,340 | +1086.6% | 4.27% | +820.5% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $117,308,000 | +121.2% | 2,550,178 | +108.2% | 4.23% | +73.9% |
| MNKKQ | New | MALLINCKRODT PUB LTD CO | $107,649,000 | – | 2,402,350 | +100.0% | 3.88% | – |
| PCRX | Buy | PACIRA PHARMACEUTICALS INC | $85,564,000 | +70.6% | 1,793,799 | +63.1% | 3.09% | +34.2% |
| CAH | New | CARDINAL HEALTH INC | $84,496,000 | – | 1,084,396 | +100.0% | 3.05% | – |
| HOLX | New | HOLOGIC INC | $76,604,000 | – | 1,688,060 | +100.0% | 2.76% | – |
| HAE | Buy | HAEMONETICS CORP | $73,249,000 | +12.8% | 1,854,872 | +15.9% | 2.64% | -11.2% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $68,495,000 | +49.3% | 2,031,890 | +31.1% | 2.47% | +17.4% |
| ZBH | New | ZIMMER BIOMET HLDGS INC | $65,154,000 | – | 507,430 | +100.0% | 2.35% | – |
| HUM | Buy | HUMANA INC | $59,938,000 | +132.6% | 249,098 | +99.3% | 2.16% | +83.0% |
| ABBV | New | ABBVIE INC | $57,967,000 | – | 799,430 | +100.0% | 2.09% | – |
| MD | New | MEDNAX INC | $56,913,000 | – | 942,730 | +100.0% | 2.05% | – |
| AGN | New | ALLERGAN PLC | $50,733,000 | – | 208,700 | +100.0% | 1.83% | – |
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $45,418,000 | +85.6% | 815,120 | +81.1% | 1.64% | +45.9% |
| XLV | New | SELECT SECTOR SPDR TRsbi healthcare | $37,463,000 | – | 472,780 | +100.0% | 1.35% | – |
| CNC | New | CENTENE CORP DEL | $34,577,000 | – | 432,864 | +100.0% | 1.25% | – |
| WBA | New | WALGREENS BOOTS ALLIANCE INC | $33,231,000 | – | 424,350 | +100.0% | 1.20% | – |
| CLVS | New | CLOVIS ONCOLOGY INCcall | $32,771,000 | – | 350,000 | +100.0% | 1.18% | – |
| ESRX | New | EXPRESS SCRIPTS HLDG COcall | $31,920,000 | – | 500,000 | +100.0% | 1.15% | – |
| BMY | New | BRISTOL MYERS SQUIBB COcall | $27,860,000 | – | 500,000 | +100.0% | 1.00% | – |
| LLY | New | LILLY ELI & CO | $26,917,000 | – | 327,064 | +100.0% | 0.97% | – |
| LIVN | New | LIVANOVA PLC | $24,484,000 | – | 400,000 | +100.0% | 0.88% | – |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $13,110,000 | – | 150,000 | +100.0% | 0.47% | – |
| BSX | New | BOSTON SCIENTIFIC CORP | $12,583,000 | – | 453,950 | +100.0% | 0.45% | – |
| VAR | New | VARIAN MED SYS INCput | $10,319,000 | – | 100,000 | +100.0% | 0.37% | – |
| HRC | New | HILL ROM HLDGS INC | $9,951,000 | – | 125,000 | +100.0% | 0.36% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HCA HOLDINGS INC | 27 | Q1 2022 | 6.2% |
| ZIMMER HLDGS INC | 26 | Q2 2022 | 9.3% |
| DANAHER CORPORATION | 26 | Q3 2022 | 5.6% |
| NEUROCRINE BIOSCIENCES INC | 26 | Q4 2022 | 7.8% |
| UNITEDHEALTH GROUP INC | 24 | Q3 2022 | 6.4% |
| VERTEX PHARMACEUTICALS INC | 24 | Q3 2021 | 5.3% |
| HUMANA INC | 22 | Q3 2022 | 6.6% |
| BRISTOL-MYERS SQUIBB CO | 22 | Q3 2022 | 9.2% |
| BIOGEN INC | 21 | Q3 2022 | 8.5% |
| LABORATORY CORP AMER HLDGS | 20 | Q2 2020 | 8.3% |
View HealthCor Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CareView Communications Inc | May 26, 2023 | 186,970,000 | 32.0% |
| Research Alliance Corp. IISold out | February 14, 2023 | 0 | 0.0% |
| ARYA Sciences Acquisition Corp IVSold out | February 14, 2022 | 0 | 0.0% |
| Aurinia Pharmaceuticals Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| MADRIGAL PHARMACEUTICALS, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Medicus Sciences Acquisition Corp.Sold out | February 14, 2022 | 0 | 0.0% |
| Arcturus Therapeutics Holdings Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| Intersect ENT, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| NEVRO CORP | February 12, 2021 | 156,046 | 0.5% |
| ViewRay, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
View HealthCor Management, L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2023-05-26 |
| 4 | 2023-05-26 |
| SC 13D/A | 2023-05-26 |
| 4 | 2023-04-04 |
| 4 | 2023-04-04 |
| SC 13D/A | 2023-04-03 |
| 13F-HR | 2023-02-15 |
| SC 13G/A | 2023-02-14 |
| 4 | 2023-01-04 |
| 4 | 2023-01-04 |
View HealthCor Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.